Pharmacy Times May 25, 2022

Dong Xu, PhD, MS, curators’ distinguished professor at the University of Missouri College of Engineering, discusses how artificial intelligence is being used to develop new drug therapies for medical treatments targeting cancers and other diseases.

Pharmacy Times interviewed Dong Xu, PhD, MS, curators’ distinguished professor, Department of Electrical Engineering and Computer Science, University of Missouri College of Engineering, on research assessing the application of a form of artificial intelligence (AI) to help scientists develop new drug therapies for medical treatments targeting cancers and other diseases.

Alana Hippensteele: Hi, I’m Alana Hippensteele with Pharmacy Times. Joining me is Dong Xu, PhD, MS, a curators’ distinguished professor in the Department of Electrical Engineering and Computer Science at the University of Missouri College...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Interview / Q&A, Provider, Technology, Trends
Related Articles:
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Alphabet shares jump 14% on earnings beat, first-ever dividend
Microsoft: Unlocking AI Benefits Will Require Cultural Changes for Enterprises
Zephyr AI Raises $111 Million in Series A Financing
Chatbot answers are all made up. This new tool helps you figure out which ones to trust.

Share This Article